Bausch & Lomb (BLCO) Change in Receivables (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Change in Receivables came in at $53.0 million in Q2 2026, up 6.0% YoY from $50.0 million in Q2 2025, and up 149.07% on a QoQ basis from -$108.0 million in Q1 2026.
Bausch & Lomb (BLCO) Change in Receivables (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Change in Receivables data on file, last reported at $53.0 million in Q2 2026.
- Quarterly Change in Receivables rose 6.0% year-over-year to $53.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $89.0 million (up 36.92% YoY) and the FY2025 annual result came in at $148.0 million, down 34.8% from the prior year.
- Change in Receivables grew to $53.0 million in Q2 2026, from -$108.0 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $130.0 million in Q4 2025 to a low of -$108.0 million in Q1 2026.
- A 5-year average of $29.8 million and a median of $33.0 million in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables soared 2700.0% — and 2024, when it slumped 825.0%.
- Tracing BLCO's Change in Receivables over 5 years: stood at $27.0 million in 2022, then surged by 44.44% to $39.0 million in 2023, then soared by 205.13% to $119.0 million in 2024, then increased by 9.24% to $130.0 million in 2025, then tumbled by 59.23% to $53.0 million in 2026.
- The last three Change in Receivables figures came in at $53.0 million (Q2 2026), -$108.0 million (Q1 2026), and $130.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 74.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 37.21 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 252.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 156.00 Mn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | 53.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.00 Mn |
| Jun 30, 2026 | 53.00 Mn |
| Mar 31, 2026 | -108.00 Mn |
| Mar 31, 2026 | -108.00 Mn |
| Dec 31, 2025 | 130.00 Mn |
| Dec 31, 2025 | 130.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 50.00 Mn |
| Jun 30, 2025 | 50.00 Mn |
| Mar 31, 2025 | -46.00 Mn |
| Mar 31, 2025 | -46.00 Mn |
| Dec 31, 2024 | 119.00 Mn |
| Dec 31, 2024 | 119.00 Mn |
| Sep 30, 2024 | -58.00 Mn |
| Sep 30, 2024 | -58.00 Mn |
| Jun 30, 2024 | 74.00 Mn |
| Jun 30, 2024 | 74.00 Mn |
| Mar 31, 2024 | 92.00 Mn |
| Mar 31, 2024 | 92.00 Mn |